Complete Genome Sequences of Bordetella pertussis Isolates with Novel Pertactin-Deficient Deletions

Michael R Weigand1, Yanhui Peng2, Pamela K Cassiday2

  • 1Centers for Disease Control and Prevention, Atlanta, Georgia, USA mweigand@cdc.gov.

Genome Announcements
|September 16, 2017
PubMed

Insights

Pertactin deficiency is common in Bordetella pertussis clinical isolates in the US due to mutations. This study reveals novel deletions causing pertactin deficiency in four Bordetella pertussis isolates.

Area of Science:

  • Microbiology
  • Genomics
  • Vaccinology

Background:

  • The respiratory pathogen Bordetella pertussis causes whooping cough.
  • Clinical isolates of Bordetella pertussis in the US are increasingly deficient in pertactin, a key component of acellular vaccines.
  • This deficiency arises from various independent genetic mutations.

Purpose of the Study:

  • To investigate the genetic basis of pertactin deficiency in recent Bordetella pertussis clinical isolates.
  • To sequence and analyze the genomes of Bordetella pertussis isolates lacking pertactin.

Main Methods:

  • Whole-genome sequencing of four Bordetella pertussis clinical isolates.
  • Bioinformatic analysis to identify genetic variations, specifically deletions, responsible for pertactin deficiency.

Main Results:

  • Complete genome sequences for four Bordetella pertussis isolates were determined.
  • Novel deletions within the Bordetella pertussis genome were identified as the cause of pertactin deficiency in these isolates.

Conclusions:

  • The findings elucidate novel genetic mechanisms leading to pertactin deficiency in Bordetella pertussis.
  • Understanding these genomic alterations is crucial for monitoring vaccine effectiveness and pathogen evolution.

Related Concept Videos